Antonin Lévy

7.6k total citations · 1 hit paper
266 papers, 4.7k citations indexed

About

Antonin Lévy is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Antonin Lévy has authored 266 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Pulmonary and Respiratory Medicine, 109 papers in Oncology and 70 papers in Surgery. Recurrent topics in Antonin Lévy's work include Lung Cancer Treatments and Mutations (44 papers), Lung Cancer Research Studies (37 papers) and Lung Cancer Diagnosis and Treatment (36 papers). Antonin Lévy is often cited by papers focused on Lung Cancer Treatments and Mutations (44 papers), Lung Cancer Research Studies (37 papers) and Lung Cancer Diagnosis and Treatment (36 papers). Antonin Lévy collaborates with scholars based in France, United States and United Kingdom. Antonin Lévy's co-authors include Éric Deutsch, Cyrus Chargari, C. Le Péchoux, Jean‐Charles Soria, Nicolas Magné, Yungan Tao, Christophe Massard, Louis D. Van de Kar, Peter A. Rittenhouse and Pierre Blanchard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Antonin Lévy

246 papers receiving 4.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis

2016 307 citations Dario Callegaro, Rosalba Miceli et al. The Lancet Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Antonin Lévy	1.8k	1.8k	941	812	602	266	4.7k
Matthew G. Ewend	1.4k 0.8×	1.4k 0.8×	759 0.8×	925 1.1×	603 1.0×	112	4.9k
Heath D. Skinner	1.3k 0.7×	1.6k 0.9×	1.1k 1.1×	1.5k 1.8×	414 0.7×	159	4.4k
Michael Bamberg	2.3k 1.3×	1.0k 0.6×	1.3k 1.4×	1.3k 1.6×	1.0k 1.7×	179	6.9k
Dirk Vordermark	1.2k 0.7×	1.1k 0.6×	569 0.6×	1.4k 1.7×	713 1.2×	222	4.7k
Qin Li	1.2k 0.6×	1.3k 0.7×	495 0.5×	1.1k 1.4×	257 0.4×	154	3.9k
Donn C. Young	1.1k 0.6×	1.8k 1.0×	1.4k 1.5×	1.2k 1.5×	823 1.4×	137	5.7k
Lai Wei	852 0.5×	2.2k 1.2×	1.1k 1.1×	1.3k 1.6×	501 0.8×	277	6.0k
Thomas Filleron	1.4k 0.8×	2.1k 1.2×	803 0.9×	1.1k 1.4×	420 0.7×	222	4.9k
James M. Larner	1.8k 1.0×	943 0.5×	726 0.8×	1.1k 1.4×	851 1.4×	151	4.3k
Michael Schwartz	1.1k 0.6×	1.9k 1.1×	794 0.8×	617 0.8×	231 0.4×	83	4.2k

Countries citing papers authored by Antonin Lévy

Since Specialization

Citations

This map shows the geographic impact of Antonin Lévy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonin Lévy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonin Lévy more than expected).

Fields of papers citing papers by Antonin Lévy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonin Lévy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonin Lévy. The network helps show where Antonin Lévy may publish in the future.

Co-authorship network of co-authors of Antonin Lévy

This figure shows the co-authorship network connecting the top 25 collaborators of Antonin Lévy. A scholar is included among the top collaborators of Antonin Lévy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonin Lévy. Antonin Lévy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Remón, Jordi, Antonin Lévy, Lizza Hendriks, et al.. (2025). Unresectable stage III non-small-cell lung cancer: state of the art and challenges. Nature Reviews Clinical Oncology. 23(1). 22–39.

Lévy, Antonin, Christophe Massard, Stefan Michiels, & Éric Deutsch. (2025). Innovative, early-phase clinical trials of drug–radiotherapy combinations. The Lancet Oncology. 26(4). e190–e202. 3 indexed citations

Thomas, P., Jordi Remón, Angela Botticella, et al.. (2024). Quel traitement local pour la prise en charge des CBNPC oligométastatiques ?. Revue des Maladies Respiratoires Actualités. 16(2). 2S94–2S108.

Houda, Ilias, Chris Dickhoff, Carin A. Uyl‐de Groot, et al.. (2024). Challenges and controversies in resectable non-small cell lung cancer: a clinician’s perspective. The Lancet Regional Health - Europe. 38. 100841–100841. 17 indexed citations

Tagliamento, Marco, Damien Vasseur, Jordi Remón, et al.. (2024). Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer. Cancer Treatment Reviews. 129. 102791–102791. 13 indexed citations

Houda, Ilias, Chris Dickhoff, Carin A. Uyl‐de Groot, et al.. (2024). New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe. The Lancet Regional Health - Europe. 38. 100840–100840. 18 indexed citations

Botticella, Angela, Angela Botticella, Benjamin Besse, et al.. (2024). Postoperative radiotherapy results in 192 epithelial thymic tumours patients with 10 years of follow-up. Radiotherapy and Oncology. 195. 110272–110272. 1 indexed citations

Lévy, Antonin, Chad G. Rusthoven, Paul D. Brown, C. Le Péchoux, & Corinne Faivre‐Finn. (2024). Prophylactic Cranial Irradiation for Patients With SCLC—A New Perspective in the Immunotherapy Era. Journal of Thoracic Oncology. 20(3). 395–398. 4 indexed citations

Ngo, Carine, et al.. (2024). 87P Characteristics and outcomes of 11 patients with myoepithelial tumors: The Gustave Roussy experience. ESMO Open. 9. 102476–102476.

10.

Khalifa, Jonathan, Antonin Lévy, S. Thureau, et al.. (2023). Radiotherapy in the management of synchronous metastatic lung cancer. Cancer/Radiothérapie. 28(1). 22–35.

11.

Tagliamento, Marco, Édouard Auclin, Mihaela Aldea, et al.. (2023). Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. European Journal of Cancer. 182. 107–114. 25 indexed citations

12.

Ghigna, Maria‐Rosa, J. Remon Masip, Damien Vasseur, et al.. (2023). 1334P Activity of first line immunotherapy or chemo-immunotherapy in advanced NSCLC with SMARCA4 deficiency. Annals of Oncology. 34. S769–S769. 2 indexed citations

13.

Sun, Roger, Alexandre Carré, Sophie Bockel, et al.. (2022). Imaging approaches and radiomics: toward a new era of ultraprecision radioimmunotherapy?. Journal for ImmunoTherapy of Cancer. 10(7). e004848–e004848. 22 indexed citations

14.

Moya‐Plana, Antoine, Lambros Tsélikas, O. Lambotte, et al.. (2022). Postgraduate oncology educational shifts during the COVID-19 pandemic: results of faculty and medical student surveys. ESMO Open. 7(2). 100451–100451. 3 indexed citations

15.

Giaj‐Levra, Niccolò, Matteo Giaj Levra, Valérie Durieux, et al.. (2019). Defining Synchronous Oligometastatic Non–Small Cell Lung Cancer: A Systematic Review. Journal of Thoracic Oncology. 14(12). 2053–2061. 38 indexed citations

16.

Callegaro, Dario, Rosalba Miceli, Sylvie Bonvalot, et al.. (2018). Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres. European Journal of Cancer. 105. 19–27. 46 indexed citations

17.

Delhorme, Jean‐Baptiste, Andrea Fontana, Antonin Lévy, et al.. (2016). Renal angiomyolipomas: At least two diseases. A series of patients treated at two European institutions. European Journal of Surgical Oncology. 43(4). 831–836. 14 indexed citations

18.

Ferté, Charles, Antoine Hollebecque, Serge Koscielny, et al.. (2013). Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials. Clinical Cancer Research. 20(1). 246–252. 130 indexed citations

19.

Nassar, Dany, N. Schartz, C. Bouché, et al.. (2010). Kaposi’s Sarcoma after Long-Acting Steroids: Time until Remission and Drug Washout. Dermatology. 220(2). 159–163. 7 indexed citations

20.

Lévy, Antonin, et al.. (1998). [Hepatic amebiasis: an unusual clinical presentation].. PubMed. 27(24). 1216–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact